Free Shipping Within the US
Money Back Guarantee

CANNABIGEROLIC ACID MONOETHYLETHER (CBGAM)

Dale blog imageAuthor: Dale Hewett
CBGAM molecule structure
Table of Contents (Scrollable)

CBG, or cannabigerol, is a class of cannabinoids produced by the cannabis plant. Of this class of major cannabinoids, Cannabigerolic acid monomethyl ether (CBGAM) is a sister molecule.

What is Cannabigerolic Acid Monoethylether (CBGAM)?

There is no accurate record of when CBGAM was discovered. However, we do know when it’s mother cannabinoid, CBG (cannabigerol) was discovered. In 1964, researchers Yehiel Gaoni and Raphael Mechoulam discovered cannabigerol (CBG), a compound isolated from hashish made from the marijuana plant.

During this same experiment, it was also discovered that Cannabigerolic Acid (CBGA) is the primary cannabinoid formed in the cannabis plant. Not only is it the primary cannabinoid, but CBGA is responsible for forming many other cannabinoids found.

Cbg Vs Cbd Molecule

There really is not much verifiable information or studies available about CBGAM. We can gather, though, that cannabinoids like CBDA, THCA, CBCA, and CBGMA are isolated using a simple technique called chromatography. This process is used with a clean, domestic cannabis strain. Cannabinoids are then isolated, accordingly.

There is a restriction in the study of some cannabinoids because of their psychoactive effects. CBGAM is at its initial stage of research and development. Almost every compound present in the cannabis plant is known to have distinctive properties that are useful for the human body.

We hope to see more research on CBGAM that will contribute to a more comprehensive understanding of the compound and its’ potential effects.

How Does Cannabigerolic Acid Monoethylether Work?

There is little to no accurate reporting on how CBGAM works in the body. Since CBGAM is part of the cannabigerol class, there is a chance that CBGAM might have a mechanism of action associated with CBG. Again, there just isn’t much we know about this cannabinoid at this time.

Just as it is with other cannabinoids, CBGs functions by impacting the Endocannabinoid System (ECS). Endocannabinoids are produced naturally by the body, and they are responsible for the regulation of physiological functions and maintenance of internal balance.

Although the method of the mechanism is still unknown, researchers speculate that CBG may have a different way of interacting with cannabinoid receptors. 

Possible Therapeutic Benefits of CBGAM

Since Cannabigerolic acid Monomethyl ether (CBGAM) belongs to the category of the CBG, there are chances that CBGAM might have similar therapeutic/medicinal benefits to CBG.

Most of the studies performed on CBG were done on lab animals and not humans. However, there are reasons to believe that this compound might have similar effects when used on human beings.

More About CBG

CBG is a non-psychoactive compound that is reported to be  an analgesic compound and anti-inflammatory. It has also been reported to treat glaucoma by reducing painful intraocular eye pressure.

This is done through the work of the endocannabinoid system. You can watch this video for more information on this bodily system:

Interesting Facts About CBGAM

 

Property Name Property Value Reference
Molecular Weight 374.5 Computed by PubChem 2.1 (PubChem release 2021.05.07)
XLogP3-AA 7.8 Computed by XLogP3 3.0 (PubChem release 2021.05.07)
Hydrogen Bond Donor Count 2 Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)
Hydrogen Bond Acceptor Count 4 Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)
Rotatable Bond Count 11 Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)
Exact Mass 374.24570956 Computed by PubChem 2.1 (PubChem release 2021.05.07)
Monoisotopic Mass 374.24570956 Computed by PubChem 2.1 (PubChem release 2021.05.07)
Topological Polar Surface Area 66.8 Ų Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)
Heavy Atom Count 27 Computed by PubChem
Formal Charge 0 Computed by PubChem
Complexity 505 Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)
Isotope Atom Count 0 Computed by PubChem
Defined Atom Stereocenter Count 0 Computed by PubChem
Undefined Atom Stereocenter Count 0 Computed by PubChem
Defined Bond Stereocenter Count 1 Computed by PubChem
Undefined Bond Stereocenter Count 0 Computed by PubChem
Covalently-Bonded Unit Count 1 Computed by PubChem
Compound Is Canonicalized Yes Computed by PubChem (release 2021.05.07)

Table provided by Pub Chem

A research carried out on rat models showed CBG protects against neurodegenerative diseases like Huntington’s diseases.

Another promising use of CBG is in the treatment of Inflammatory Bowel Diseases (IBDs), ulcerative colitis and Crohn’s disease. 

Since Cannabigerolic acid Monomethyl ether (CBGAM) belongs to the CBG cannabinoid class, there are chances that CBGAM might have similar therapeutic/medicinal benefits to CBG.

References

Valdeolivas S., et al, Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate lesioned mice. Neurotherapeutics. 2015 Jan;12(1):185-99. doi: 10.1007/s13311-014-0304-z.

Colasanti, BK., A Comparison of the Ocular and Central Effects of Δ9-Tetrahydrocannabinol and Cannabigerol. Journal of Ocular Pharmacology and TherapeuticsVol. 6, No. 4.#

Borellis, F. et al, Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis derived non-psychotropic cannabinoid. Carcinogenesis, Volume 35, Issue 12, December 2014, Pages 2787–2797, 

Back to List of Cannabinoids

blog BG
Table of Contents

Search our website for more information on CBD:

Related Cannabinoids

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett Author
Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.

la wire logo
yahoo finance greyscale
forbes logo
Markets Insider Logo
chicago journal logo greyscale